Atjaunināt sīkdatņu piekrišanu

Handbook of Modern Pharmaceutical Analysis, Volume 3 [Hardback]

Edited by (R.W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey, U.S.A.), Edited by (President, Ahuja Consulting for Water Quality, Calabash, NC, USA)
  • Formāts: Hardback, 566 pages, height x width: 254x152 mm, weight: 1200 g
  • Sērija : Separation Science and Technology
  • Izdošanas datums: 02-Aug-2001
  • Izdevniecība: Academic Press Inc
  • ISBN-10: 0120455552
  • ISBN-13: 9780120455553
Citas grāmatas par šo tēmu:
  • Formāts: Hardback, 566 pages, height x width: 254x152 mm, weight: 1200 g
  • Sērija : Separation Science and Technology
  • Izdošanas datums: 02-Aug-2001
  • Izdevniecība: Academic Press Inc
  • ISBN-10: 0120455552
  • ISBN-13: 9780120455553
Citas grāmatas par šo tēmu:
This compilation of 16 papers considers various aspects of pharmaceutical analysis as it relates to new drug development, production, control, and regulation. The book begins with methods for solid state analysis, degradation and impurity analysis, preformulation studies, and solid dosage form analysis, such as spectroscopy, chromatography, x-ray diffraction, and differential scanning calorimetry. Later papers discuss new drug delivery systems, compendial testing, method development, setting specifications, method validation, proper documentation, and microfabricated electrophoresis devices. Annotation c. Book News, Inc., Portland, OR (booknews.com)

This book describes the role modern pharmaceutical analysis plays in the development of new drugs. Detailed information is provided as to how the quality of drug products is assured from the point of discovery until the patient uses the drug. Coverage includes state-of-the-art topics such as analytics for combinatorial chemistry and high-throughput screening, formulation development, stability studies, international regulatory aspects and documentation, and future technologies that are likely to impact the field. Emphasis is placed on current, easy-to-follow methods that readers can apply in their laboratories.

No book has effectively replaced the very popular text, Pharmaceutical Analysis, that was edited in the 1960s by Tak Higuchi. This book will fill that gap with an up-to-date treatment that is both handy and authoritative.

Recenzijas

In today's pharmaceutical industry, the analytical department plays a major role in the drug development process, providing accurate and precise data to support drug discovery, development, and market support. This handbook presents analytical research and development as a process-driven function assuring identity, safety, efficacy, purity, and quality of a product. Regulatory requirements and compliance are discussed as well as attempts to harmonize international regulatory authorities. Analytical techniques from the molecular to the bulk level, new drug discoveries, identification of impurities, various routes of administration, stability testing, and analytical documentation are all parts of the regulatory requirements during pre-approval inspections.

"This book is well referenced and indexed. Each of the 16 chapters is written by experts and illustrated with figures, tables, and graphs. Anyone involved with new drug development, production, and control in the pharmaceutical industry would fine this title useful as well as graduate students and faculty in these areas. This would be a good acquisition for a graduate or research chemical or pharmaceutical library." --E-Streams E-STREAMS Vol. 5, No. 6 - June 2002

"On the whole this well written and thoroughly edited volume brings the reader up to date on a wide range of subjects pertaining to analytics in pharmaceutical industry." --Alexander Nezlin, CTS Chemical Industries Ltd, Kiryat Malachi, Israel

Contributors xiii Preface xvii Modern Pharmaceutical Analysis: An Overview Satinder Ahuja Identity and Purity Requirements 2(2) Bioavailability/Dissolution Requirements 4(1) Regulatory Considerations 5(3) Regulatory Compliance 8(1) International Conference on Harmonization 9(1) Global CMC NDA 9(1) Highlights of Modern Pharmaceutical Analysis 10(14) References 22(2) Combinatorial Chemistry and High-Throughput Screening in Drug Discovery and Development Ken Appell John J. Baldwin William J. Egan Introduction 24(1) Combinatorial Methods 25(1) Methods for Structural Assignment 26(2) Diversity 28(1) Druglikeness 28(1) Designing Combinatorial Libraries with Optimal ADME Properties 28(2) Existing Computational Methods for ADME Properties 30(5) Optimization Philosophy 35(2) Applying Existing ADME Models to Combinatorial Library Design 37(1) The Future of ADME Modeling 38(1) High-Throughput Screening and Combinatorial Chemistry 39(1) Assay Plate Formats: Move to Miniaturization 40(3) Nonseparation or Homogeneous Assays 43(1) Identification of Receptor Antagonists for Chemokine Receptor and Bradykinin-1 by Screening a 150,000-Member Combinatorial Library 44(3) Structure-based Design of Somatostatin Agonists 47(1) Conclusions 48(9) References 49(8) Solid-State Analysis Harry G. Brittain Introduction 57(1) Properties Associated with the Molecular Level 58(7) Properties Associated with the Particulate Level 65(8) Properties Associated with the Bulk Level 73(8) Summary 81(5) References 81(5) Degradation and Impurity Analysis for Pharmaceutical Drug Candidates Karen M. Alsante Robert C. Friedmann Todd D. Hatajik Linda L. Lohr Thomas R. Sharp Kimberly D. Snyder Edward J. Szczesny Residual Solvents and Water 86(9) Purposeful Degradation Studies 95(24) Isolation and Identification of Impurities/Degradants 119(8) Mass Spectrometry in Identification of Impurities 127(20) Role of NMR 147(19) Reference Standards 166(2) Summary 168(5) References 168(5) Preformulation Studies Edward Lau Introduction 173(7) Preformulation Studies 180(34) Analytical Techniques and Instruments for Preformulation Studies 214(10) Regulatory Requirements for Preformulation 224(2) Summary and Conclusions 226(9) Appendix 1 227(2) Appendix 2 229(3) Appendix 3 232(1) References 232(3) Solid Dosage-Form Analysis Philip J. Palermo Introduction 235(6) Physicochemical Characterization Techniques 241(11) Near-Infrared Analysis 252(5) Automation 257(5) Future Directions 262(1) Summary 263(1) Acknowledgments 263(7) References 263(7) Parenteral Dosage Forms Gregory A. Birrer Satya S. Murthy Jie Liu Characteristics of Parenteral Dosage Forms 270(1) Pharmaceutical Analysis During Formulation and Process Development 271(1) Analytical Testing for Finished Parenteral Products 272(1) Packaging Components Testing 273(1) Process Development Support 274(1) In-Process Testing 275(1) Release Testing 276(2) Raw Material Testing 278(1) Validation of Analytical Procedure 279(2) Stability-Indicating Methods 281(1) Method Transfer 281(1) Cleaning Method Validation 282(1) Admixture Studies 282(1) Microbiological Testing of Parenteral Formulations 283(1) Sterility Testing 284(6) Bacterial Endotoxin Testing 290(2) Particulate Matter Testing 292(2) Bioburden Testing of Parenteral Product Solution 294(4) Introduction to Cleaning Validation 298(1) Swab Selection (Recovery and Compatability Studies) 298(1) Technician Qualification 298(1) Sampling 299(1) Acceptance Criteria 300(1) Methods of Analysis 301(1) Grouping/Matrix Approach 301(1) Validation Protocol 302(1) Validation Report 302(1) Summary 302(5) References 303(4) New Drug Delivery Systems David C. Pang Introduction 307(1) Oral Drug Delivery 308(2) Direct Drug Delivery 310(1) Dermatological Delivery System 311(1) Tumor-Targeted Drug Delivery Systems 311(2) Biodegradable Drug Delivery System 313(2) Protein Drug Delivery System 315(4) Devices 319(4) Summary 323(2) References 323(2) Compendial Testing Christine F. Richardson Introduction 325(1) A Brief History of the United States Pharmacopeia 326(1) Compendial Testing for Formulated Products and Active Ingredients 327(13) Which Compendium to Use and When to Use It 340(1) Validation 340(2) Harmonization of Testing Methods for Multicountry Submission 342(1) Conclusions 343(1) Acknowledgments 344(1) References 344(1) Method Development Henrik T. Rasmussen Introduction 345(1) Overview of Separation Methods 346(3) High-Performance Liquid Chromatography 349(25) Thin-Layer Chromatography 374(1) Gas Chromatography 375(1) Supercritical-Fluid Chromatography 376(3) Capillary Electrophoresis 379(4) Conclusions 383(1) Summary 383(4) References 384(3) Setting Up Specifications Ian E. Davidson Introduction 387(2) Setting Specifications at Different Stages of Drug Development 389(4) International Conference on Harmonization Guidelines 393(17) Pharmacopeias and Specifications 410(1) Statistical Considerations in Setting Specifications 411(1) Summary 412(3) References 412(3) Validation of Pharmaceutical Test Methods Jonathan B. Crowther Background and
Chapter Overview 415(3) Validation Terminology and Definitions 418(1) Method Development and Its Influence on Method Validation 419(9) Validation Requirements of The Method 428(1) Validation Documentation 428(1) Validation Experimentation 429(7) Method Transfer 436(2) Revalidation 438(1) References Standards 438(3) Summary 441(4) Acknowledgments 442(1) References 442(3) Stability Studies Jessica CHA Joseph S. Ranweiler Philip A. Lane Introduction 445(1) Operational Issues 446(15) Excipients 461(2) Drug Substance 463(8) Drug Product 471(9) Summary 480(5) Glossary 480(2) Appendix 482(1) References 483(2) Analytical Methodology Transfer Stephen Scypinski Introduction 485(1) The Drug Development Process 486(1) Types of Method Transfer 487(2) Requirements and Elements of Analytical Technology Transfer 489(3) Technical Transfer Time Line/Project Plan 492(1) Analysis of Results/Statistical Packages 493(1) Analyst Certification and Training 494(1) Transfer of Technical Ownership 494(3)
Chapter Summary 497(2) References 497(2) Pharmaceutical Analysis Documentation Hitesh Chokshi Kathleen Schostack Scope 499(1) Introduction 500(1) Pharmaceutical Analysis During Product Life Cycle 500(10) Regulatory Documents 510(6) Compliance Documents 516(4) Research Documents 520(1) Summary 521(1) Conclusions 522(7) Appendix I: References for CMC Guidances 522(3) Appendix II: U.S. NDA Table of Contents-Analytical Documentation 525(4) An Innovative Separation Platform: Electrophoretic Microchip Technology Lian Ji Jin Jerome Ferrance Zhili Huang James P. Landers Introduction 529(2) Microchip Fabrication 531(4) Detection Techniques 535(10) Pharmaceutical Potential 545(4) Concluding Remarks 549(1) Summary 549(6) References 549(6) Index 555
Satinder Ahuja is a leading expert on water quality improvement. He earned his PhD in analytical chemistry from the University of the Sciences in Philadelphia. He worked for Novartis Corp. in various leadership positions for over 25 years and taught as an adjunct professor at Pace University for over 10 years. As president of Ahuja Consulting, he advises on water quality issues relating to chemicals and pharmaceuticals. A member of the executive committee of the Rivers of the World Foundation (ROW), Dr. Ahuja has organized numerous global symposia on improving water quality, including presentations for the American Chemical Society and UNESCO. Dr. Ahuja has published numerous papers and more than 25 books. His latest books are Contaminants in Our Water (ACS, 2020); Evaluating Water Quality to Prevent Future Disasters (Elsevier, 2019); Advances in Water Purification Techniques (Elsevier, 2019); and Chemistry and Water (Elsevier, 2017). Stephen Scypinski obtained his Ph.D. in analytical chemistry from Seton Hall University. He is director of analytical chemistry research and development department at R.W. Johnson Pharmaceutical Research Institute.